Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1 * 28 or * 6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A)

BACKGROUND: Various polymorphisms have been detected in the UDP‐glucuronosyltransferase 1A (UGT1A) gene, and UGT1A1 *28 and UGT1A1 *6 have important effects on the pharmacokinetics of irinotecan and the risk of severe toxicities during irinotecan therapy. This study was conducted to determine the ma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Fukuda, Minoru, Shimada, Midori, Kitazaki, Takeshi, Nagashima, Seiji, Hashiguchi, Kohji, Ebi, Noriyuki, Takayama, Koichi, Nakanishi, Yoichi, Semba, Hiroshi, Harada, Taishi, Seto, Takashi, Okamoto, Isamu, Ichinose, Yukito, Sugio, Kenji
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217920/
https://ncbi.nlm.nih.gov/pubmed/27883280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12407
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados